logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

hul-share-price-today-live-updates-19-sep-2025.jpg
+

HUL Share Price Highlights: HUL Stock Price History

20 Sep Stock Analysis
tech-mahindra-stock-price-livestock-price-today-live-updates-19-sep-2025.jpg
+

Tech Mahindra Share Price Highlights: Tech Mahindra Stock Price History

20 Sep Stock Analysis

recent post

  • image1-1-39.jpg

    Best Crypto Presales Right Now: Promising

    Sep 20 2025
  • shutterstock_1847302678-scaled.jpg

    IG Group Expands Crypto Reach with

    Sep 20 2025
  • UE-Russie-Sanctions.png

    Crypto Enters The Battlefield In EU-Russia

    Sep 20 2025
  • Image-10-3-scaled.png

    $2.1B Crypto Losses Linked to Bribery

    Sep 20 2025
  • RIPPLE-RLSUD-scaled.jpg

    Ripple: BlackRock Signals $8+ XRP Target

    Sep 20 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.